The COVID-19 Pandemic – News and Features

Researchers are using optogenetics, the use of light to probe the functions of living tissue, to find new antiviral compounds that help our bodies more effectively respond to physiological stress.

The dynamic barrier formed by cilia helps prevent bacteria, viruses and other harmful particles from reaching the cells that line the airways and causing infection.

To accelerate cancer research, the National Institute of Standards and Technology (NIST) has released a dataset detailing the complete genetic makeup of a pancreatic cancer cell line.

Experts discuss how academic publishing must change to support open science, transparency and global accessibility in a digital-first research world.

Explore cutting-edge technologies and workflows advancing downstream processing in biopharma, driving purification efficiency and innovation in new therapies.

University of Missouri researchers uncover the antiviral potential of defensins — tiny proteins with big possibilities in future disease prevention and treatment.

UK Biobank has completed whole-body imaging scans of 100,000 participants.

Scientists have found that mesenchymal stromal cells, or MSC therapy, in combination with antiviral drugs, helped cats’ immune systems recover and reduced systemic inflammation.

By analyzing just a drop of blood, a novel microchip system, known as microfluidic EM-based polyclonal epitope mapping, gives researchers quicker-than-ever insight into how a person’s antibodies are interacting with a virus or other pathogen.

Learn how AI and machine learning enhance antibody discovery – from structure prediction to binding optimization – with robust data and lab informatics.